210 related articles for article (PubMed ID: 29989864)
1. Evaluation of the Importance of Immunological Profile for Pemphigus Vulgaris in the Light of Necessity to Modify Compensation Theory.
Öktem A; Hayran Y; Uysal Pİ; Atılan AU; Yalçın B
Acta Dermatovenerol Croat; 2018 Jun; 26(2):100-104. PubMed ID: 29989864
[TBL] [Abstract][Full Text] [Related]
2. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
[TBL] [Abstract][Full Text] [Related]
3. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
4. Salivary and Serum Anti-Desmoglein 1 and 3 ELISA and Indirect Immunofluorescence in Pemphigus Vulgaris: Correlations with Serum ELISA, Indirect Immunofluorescence and Disease Severity.
Koopai M; Mortazavi H; Khatami A; Khodashenas Z
Acta Dermatovenerol Croat; 2018 Jun; 26(2):91-99. PubMed ID: 29989863
[TBL] [Abstract][Full Text] [Related]
5. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
[TBL] [Abstract][Full Text] [Related]
6. Correlation between salivary and serum anti-desmoglein 1 and 3 antibody titres using ELISA and between anti-desmoglein levels and disease severity in pemphigus vulgaris.
De D; Khullar G; Handa S; Joshi N; Saikia B; Minz RW
Clin Exp Dermatol; 2017 Aug; 42(6):648-650. PubMed ID: 28543318
[TBL] [Abstract][Full Text] [Related]
7. Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions.
Koga H; Ohyama B; Tsuruta D; Ishii N; Hamada T; Dainichi T; Natsuaki Y; Sogame R; Fukuda S; Karashima T; Tada J; Yamashiro M; Uezato H; Chan PT; Hashimoto T
Br J Dermatol; 2012 May; 166(5):976-80. PubMed ID: 22242828
[TBL] [Abstract][Full Text] [Related]
8. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in Pemphigus Patients Measured by Area Index and Intensity Score.
Patsatsi A; Kyriakou A; Giannakou A; Pavlitou-Tsiontsi A; Lambropoulos A; Sotiriadis D
Acta Derm Venereol; 2014 Mar; 94(2):203-6. PubMed ID: 23995461
[TBL] [Abstract][Full Text] [Related]
10. Correlation of conventional and conformational anti-desmoglein antibodies with phenotypes and disease activities in patients with pemphigus vulgaris.
Li Z; Zhang J; Xu H; Jin P; Feng S; Wang B
Acta Derm Venereol; 2015 Apr; 95(4):462-5. PubMed ID: 25178305
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity.
Barnadas MA; Rubiales MV; Gich I; Gelpí C
Int J Dermatol; 2015 Nov; 54(11):1261-8. PubMed ID: 25754029
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus.
Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P
J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786
[TBL] [Abstract][Full Text] [Related]
13. Pemphigus disease activity measurements: pemphigus disease area index, autoimmune bullous skin disorder intensity score, and pemphigus vulgaris activity score.
Rahbar Z; Daneshpazhooh M; Mirshams-Shahshahani M; Esmaili N; Heidari K; Aghazadeh N; Hejazi P; Ghajarzadeh M; Chams-Davatchi C
JAMA Dermatol; 2014 Mar; 150(3):266-72. PubMed ID: 24429657
[TBL] [Abstract][Full Text] [Related]
14. Detailed profiling of anti-desmoglein autoantibodies identifies anti-Dsg1 reactivity as a key driver of disease activity and clinical expression in pemphigus vulgaris.
Naseer SY; Seiffert-Sinha K; Sinha AA
Autoimmunity; 2015 Jun; 48(4):231-41. PubMed ID: 25384535
[TBL] [Abstract][Full Text] [Related]
15. Analysis of immunological profile, clinical features and response to treatment in pemphigus.
Bardazzi F; Balestri R; Ismaili A; LA Placa M; Barisani A; Patrizi A
G Ital Dermatol Venereol; 2017 Dec; 152(6):569-577. PubMed ID: 27352177
[TBL] [Abstract][Full Text] [Related]
16. Correlation of antimuscarinic acetylcholine receptor antibody titers and antidesmoglein antibody titers with the severity of disease in patients with pemphigus.
Lakshmi MJD; Jaisankar TJ; Rajappa M; Thappa DM; Chandrashekar L; Divyapriya D; Munisamy M; Revathy G
J Am Acad Dermatol; 2017 May; 76(5):895-902. PubMed ID: 28089115
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
Sharma VK; Prasad HR; Khandpur S; Kumar A
Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
[TBL] [Abstract][Full Text] [Related]
19. Correlation of antibodies against desmogleins 1 and 3 with indirect immunofluorescence and disease status in a Greek population with pemphigus vulgaris.
Avgerinou G; Papafragkaki DK; Nasiopoulou A; Markantoni V; Arapaki A; Servitzoglou M; Katsambas A; Stavropoulos PG
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):430-5. PubMed ID: 22221266
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Tracking of Autoantibody Levels in a Pemphigus Vulgaris Patient: Support for a Role of Anti-Desmoglein 1 Autoantibodies as Predictors of Disease Progression.
Abidi NY; Lainiotis I; Malikowski G; Seiffert-Sinha K; Sinha AA
J Drugs Dermatol; 2017 Feb; 16(2):135-139. PubMed ID: 28300855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
